Get notified when TWAV files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TWAV TaoWeave, Inc. 8-K

TaoWeave raises capital via SAFE and debt financing, enters tech partnership with Manako Labs

Filed June 3, 2026 · Period ending May 28, 2026 · ~1 min read

Key Changes

  • high

    TaoWeave secured financing through a SAFE (converts to equity later) and TLDA (debt) from Manako Labs, announced June 1. Specific amounts not disclosed, but represents immediate capital infusion with future dilution risk.

    Item 7.01, 9.01 verify on EDGAR →
  • high

    Company signed technology license and distribution agreement with Manako Labs on May 28. Key terms redacted, but suggests commercial partnership for TaoWeave's technology with potential revenue implications.

    Item 9.01 - Exhibit 10.1 view on EDGAR →
  • medium

    TaoWeave issued warrants to Manako Labs as part of financing package. Warrants allow future share purchases at set price, creating potential dilution when exercised but common in startup financing.

    Item 3.02, Exhibit 4.1 view on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.

Partner

Trade TWAV commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify